Experimental Gonorrhea vaccine gets FDA fast-track as STI cases rise

Health officials are concerned over gonorrhea because it could become resistant to current treatments. GSK, based in the UK, is developing a vaccine against the sexually transmitted infection.

Related Keywords

United States ,United Kingdom ,Italy ,Spain ,France ,Massachusetts ,Americans ,Phil Dormitzer ,Francisco Jeffrey Klausner ,Drug Administration ,Bloomberg ,World Health Organization ,Fast Track ,San Francisco Jeffrey Klausner ,